$16.59
-0.15[-0.90%]
At close: Apr 24
$16.59
0[0.00%]
After Hours: 4:20PM EDT
ACADIA Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ACADIA Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | PM | ACAD | Q1 | -$0.27 | $0.06 | — | — | $118.46M | $208.91M | — | — | Get Alert |
02/27/2024 | PM | ACAD | Q4 | -$0.26 | $0.30 | $0.28 | -6.67% | $136.49M | $223.70M | $231.04M | 3.28% | Get Alert |
11/02/2023 | PM | ACAD | Q3 | -$0.17 | -$0.43 | -$0.40 | 6.98% | $130.71M | $189.51M | $211.70M | 11.71% | Get Alert |
08/02/2023 | PM | ACAD | Q2 | -$0.21 | -$0.08 | $0.01 | 112.50% | $134.56M | $157.81M | $165.24M | 4.71% | Get Alert |
05/08/2023 | PM | ACAD | Q1 | -$0.70 | -$0.21 | -$0.27 | -28.57% | $115.47M | $120.29M | $118.46M | -1.52% | Get Alert |
02/27/2023 | PM | ACAD | Q4 | -$0.27 | -$0.24 | -$0.26 | -8.33% | $130.76M | $134.07M | $136.49M | 1.81% | Get Alert |
11/02/2022 | PM | ACAD | Q3 | -$0.09 | -$0.18 | -$0.17 | 5.56% | $131.61M | $139.86M | $130.71M | -6.54% | Get Alert |
08/08/2022 | PM | ACAD | Q2 | -$0.27 | -$0.25 | -$0.21 | 16.00% | $115.22M | $130.43M | $134.56M | 3.17% | Get Alert |
05/04/2022 | PM | ACAD | Q1 | -$0.42 | -$0.60 | -$0.70 | -16.67% | $106.55M | $121.92M | $115.47M | -5.29% | Get Alert |
02/28/2022 | PM | ACAD | Q4 | -$0.42 | -$0.24 | -$0.27 | -12.50% | $121.01M | $135.60M | $130.76M | -3.57% | Get Alert |
11/08/2021 | PM | ACAD | Q3 | -$0.54 | -$0.26 | -$0.09 | 65.38% | $120.58M | $127.75M | $131.61M | 3.02% | Get Alert |
08/04/2021 | PM | ACAD | Q2 | -$0.27 | -$0.31 | -$0.27 | 12.90% | $110.10M | $126.15M | $115.22M | -8.66% | Get Alert |
05/05/2021 | PM | ACAD | Q1 | -$0.57 | -$0.53 | -$0.42 | 20.75% | $90.07M | $111.63M | $106.55M | -4.55% | Get Alert |
02/24/2021 | PM | ACAD | Q4 | -$0.34 | -$0.47 | -$0.42 | 10.64% | $98.33M | $123.20M | $121.01M | -1.78% | Get Alert |
11/04/2020 | PM | ACAD | Q3 | -$0.29 | -$0.38 | -$0.54 | -42.11% | $94.59M | $118.82M | $120.58M | 1.48% | Get Alert |
08/05/2020 | PM | ACAD | Q2 | -$0.38 | -$0.44 | -$0.27 | 38.64% | $83.20M | $103.34M | $110.10M | 6.54% | Get Alert |
05/07/2020 | PM | ACAD | Q1 | -$0.59 | -$0.48 | -$0.57 | -18.75% | $62.96M | $91.51M | $90.07M | -1.58% | Get Alert |
02/26/2020 | PM | ACAD | Q4 | -$0.50 | -$0.36 | -$0.34 | 5.56% | $59.57M | $96.76M | $98.33M | 1.62% | Get Alert |
10/30/2019 | PM | ACAD | Q3 | -$0.50 | -$0.40 | -$0.29 | 27.50% | $58.30M | $88.49M | $94.59M | 6.89% | Get Alert |
ACADIA Pharmaceuticals (ACAD) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 27, 2024 for Q4.
The Actual EPS was $0.28, which missed the estimate of $0.30.
The Actual Revenue was $231M, which beat the estimate of $223.7M.
Browse earnings estimates, EPS, and revenue on all stocks.